Lymphoma Clinical Trials in Boston

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
J
A Study of PCI-32765 (Ibrutinib) in Combination With Either Bendamustine and Rituximab or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Participants With Previously Treated Indolent Non-Hodgkin Lymphoma
Active, not recruiting
  • Lymphoma
  • Gilbert, Arizona
  • +134 more
2021-12-02
Dec 2, 2021
N
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1383 more
2021-12-01
Dec 1, 2021
N
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
Recruiting
  • Lymphoma
  • +6 more
  • Cytology Specimen Collection Procedure
  • Birmingham, Alabama
  • +139 more
2021-11-27
Nov 27, 2021
M
A Study of CPI-613 for Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lymphoma With High-Risk Translocations
Recruiting
  • Lymphoma
  • Leukemia
  • Duarte, California
  • +9 more
2021-11-16
Nov 16, 2021
B
A Study of Nivolumab in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Relapsed/Refractory Primary Testicular Lymphoma (PTL) - 2020
Completed
Has Results
  • Lymphoma
  • Birmingham, Alabama
  • +48 more
2021-11-02
Nov 2, 2021
M
Promoting Resiliency Among Lymphoma Survivors: The 3RP-Lymphoma - 2018
Completed
Has Results
  • Lymphoma
  • 3RP-Lymphoma
  • Boston, Massachusetts
    Massachusetts General Hospital
2021-11-09
Nov 9, 2021
A
ALPN-202 With PD-1 Inhibition in Advanced Malignancies
Recruiting
  • Advanced Solid Tumor
  • Lymphoma
  • Boston, Massachusetts
  • +3 more
2021-11-05
Nov 5, 2021
T
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Recruiting
  • Locally Advanced Solid Tumors
  • +3 more
  • Oral repotrectinib (TPX-0005)
  • Los Angeles, California
  • +26 more
2021-11-03
Nov 3, 2021
M
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Recruiting
  • Melanoma
  • +4 more
  • Pembrolizumab
  • Aurora, Colorado
  • +17 more
2021-11-02
Nov 2, 2021
M
Ixazomib Rollover Study
Active, not recruiting
  • Multiple Myeloma
  • +2 more
  • Atlanta, Georgia
  • +23 more
2021-10-26
Oct 26, 2021
M
TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)
Active, not recruiting
  • Acute Leukemia
  • +3 more
  • Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Methotrexate
  • +5 more
  • Birmingham, Alabama
  • +38 more
2021-10-25
Oct 25, 2021
M
CAR-37 T Cells In Hematologic Malignancies
Recruiting
  • Hematologic Malignancy
  • +5 more
  • CAR-37 T cells
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
2021-10-28
Oct 28, 2021
E
Study of Intratumorally Administered Stimulator of Interferon Genes (STING) Agonist E7766 in Participants With Advanced Solid Tumors or Lymphomas - INSTAL-101
Recruiting
  • Lymphoma
  • Advanced Solid Tumors
  • New Haven, Connecticut
  • +7 more
2021-10-21
Oct 21, 2021
B
Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma - 2021
Completed
Has Results
  • Lymphoma
  • Multiple Myeloma
  • Muscle Shoals, Alabama
  • +215 more
2021-09-24
Sep 24, 2021
D
UPLYFT For Lymphoma Survivors
Not yet recruiting
  • Lymphoma
  • Survivorship
  • Interview with Clinicians
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
2021-10-05
Oct 5, 2021
D
Axi-cel in CNS Lymphoma
Recruiting
  • Lymphoma
  • Lymphoma Cns
  • Boston, Massachusetts
    Dana Farber Cancer Institute
2021-10-12
Oct 12, 2021
L
Phase 1 Study to Determine the MTD, Safety, Tolerability, PK and Preliminary Anti-tumor Effects of LNS8801alone and With Pembrolizumab
Recruiting
  • Solid Tumor, Adult
  • Lymphoma
  • LNS8801 -Small molecule, orally bioavailable, selective agonist of GPER
  • Pembrolizumab - anti-PD-1 antibody
  • Los Angeles, California
  • +7 more
2021-10-11
Oct 11, 2021
M
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
Recruiting
  • Lymphoma
  • Miami, Florida
  • +6 more
2021-09-29
Sep 29, 2021
F
Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study
Not yet recruiting
  • Clinical Stage I Cutaneous Melanoma AJCC v8
  • +33 more
  • Informational Intervention
  • +4 more
  • Los Angeles, California
  • +4 more
2021-09-20
Sep 20, 2021
R
Study of Cemiplimab and REGN1979 in Patients With Lymphoma
Active, not recruiting
  • Lymphoma
  • Santa Monica, California
  • +21 more
2021-09-20
Sep 20, 2021
M
Home Hospital for Lymphoma - 2021
Withdrawn
  • Lymphoma
  • Home Hospital for Lymphoma
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
2021-08-31
Aug 31, 2021
C
Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas
Active, not recruiting
  • Anaplastic Large Cell Lymphoma
  • +4 more
  • Laboratory Biomarker Analysis
  • Questionnaire Administration
  • Birmingham, Alabama
  • +106 more
2021-09-02
Sep 2, 2021
C
Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant
Recruiting
  • Hematopoietic and Lymphoid System Neoplasm
  • +3 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +3 more
  • Birmingham, Alabama
  • +42 more
2021-08-23
Aug 23, 2021
I
Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss
Recruiting
  • Advanced Solid Tumors
  • Lymphoma
  • New Haven, Connecticut
  • +5 more
2021-08-17
Aug 17, 2021
A
Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Active, not recruiting
Has Results
  • Leukemia
  • Lymphoma
  • rituximab
  • +7 more
  • Duarte, California
  • +24 more
2021-08-16
Aug 16, 2021